Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Abroad (travel likely)Recruiting

Conditions

Ovarian Neoplasms · Ovarian Epithelial Carcinoma · Fallopian Tube Neoplasms · High Grade Ovarian Serous Adenocarcinoma · Stage I Ovarian Cancer · Stage II Ovarian Cancer · Stage III Ovarian Cancer AJCC v8 · Stage IIIA Ovarian Cancer AJCC v8 · Stage IIIA1 Ovarian Cancer AJCC v8 · Stage IIIA2 Ovarian Cancer AJCC v8 · Stage IIIB Ovarian Cancer AJCC v8 · Stage IIIC Ovarian Cancer AJCC v8 · Stage IV Ovarian Cancer AJCC v8 · Stage IVA Ovarian Cancer AJCC v8 · Stage IVB Ovarian Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

    Contact: Study coordinator (Beth Scanlan) · BScanlan@uams.edu · 501-686-8274
    Contact: Principal Investigator (Kristin Zorn, MD)
  • Kaiser Permanente - San Francisco, San Francisco, California, United States

  • Anne Arundel Health System, Annapolis, Maryland, United States

    Contact: Study coordinator (Jaci Miller) · jmiller9@aahs.org · 443-481-5738
    Contact: Principal Investigator (Monica Jones, MD)
  • Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

    Contact: Study coordinator (Rebecca Stone, MD) · rstone15@jhmi.edu
    Contact: Principal Investigator (Rebecca Stone, MD)
  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Tina Colella) · tcolella@partners.org · 617-643-5150
    Contact: Principal Investigator (Amy Bregar, MD)
  • The Swedish Hospital, Seattle, Washington, United States

    Contact: Study coordinator (Robert Pearhill) · rpearhil@fredhutch.org · 206-667-3278
    Contact: Principal Investigator (Charles Drescher, MD)
Study leads
  • Christos Patriotis, PhD

    Study Director

    National Cancer Institute (NCI)